Panel Discussion: Millennials to Perennials: Diverse Perspectives on Investing with iSelect

Kathy Lintz – Founder & Partner, Matter Family Office
Andy Daniels – Founder & CEO, Daniels Trading/Global Asset Advisors
Max Williams – Managing Director, Lagomaj Capital
Rick Imperiale – Founder & President, Uniplan Companies

Cultural influences, as well as early investment experiences, can shape a lifetime of investment behavior. We will explore unique perspectives, and better understand how different generations are managing change, especially as it relates to technology. In this lively exchange, we will also discuss how the ability to invest in early stage venture capital deals can and has changed the dynamics of succession planning. And, how the investment outlook of the digitally native generation is becoming a driving force behind the new “personalized experience” being demanded across all industries.

Panel Discussion: Future of Health

Dave Messina, PhD – Chief Operating Officer, Cofactor Genomics
Meridith Unger – Founder & CEO, Nix Biosensors
Philip Strandwitz, PhD – Co-Founder & CEO, Holobiome Inc.

Healthcare is massive economic burden in this country. According to the National Health Expenditure Accounts, it now totals roughly $3.5 trillion per year, or more than $10,000 per person. That’s more than any other country in the world, despite the fact that U.S. life expectancy continues to fall below the average of other high-income countries. Something has to change. We have to simultaneously improve quality and reduce cost.

Next-Gen Treatments for Mental Health

Philip Strandwitz, PhD – Co-Founder & CEO, Holobiome Inc.

In the body, everything works together. That’s why next-generation treatments for mental health are looking away from the brain exclusively and focusing on areas such as the gut-brain axis, which links the emotional and cognitive centers of the brain with peripheral intestinal functions, and the gut biome. Because, what happens in our gut directly impacts how we feel mentally, opening doors to new approaches for anxiety, depression and more.

Power of Faster Diagnostics

Fred Turner – Co-Founder & CEO, Shield Bio

In healthcare, speed matters. Consider the power of early diagnosis and treatment in cases such as cancer, infectious diseases, and Alzheimer’s. It could literally mean the difference between life and death. That’s why innovative companies are now working to diagnose diseases in minutes instead of days, and with the right diagnosis, so therapies work the first time.This has the potential of redefining what medical care is all about.

Personalized Medicine

Dave Messina, PhD – Chief Operating Officer, Cofactor Genomics

Medicine has always been a science of averages. Most people in the population tend to suffer from most of the same diseases, and most of those diseases respond to most of the same treatments. But it isn’t perfect. This is why the idea of “personalized medicine” — or treatments that are developed and administered on a patient-by-patient basis — has always been such a desirable goal for medical researchers. No more averaging together the most likely solutions. And it is possible now.